INTRODUCTION {#sec1_1}
============

Zinc is one of the essential trace elements and a member of the major micronutrients which have attained prominence in human health and nutrition ([@B1]). It is required for many biological functions, including DNA synthesis, cell division, gene expression, and stabilization of molecular structures. It is also vital for the activity of more than 300 enzymes participating in the metabolism of macronutrients, micronutrients, and nucleic acids ([@B2], [@B3]). Since its importance for human physiology was identified in 1963, many studies witnessed its crucial importance for immune function, linear growth and gain in weight, and neuropsychological and cognitive functions of human beings. Its involvement in such diverse and fundamental activities probably accounts for its essentiality for all forms of life ([@B3]).

Poor maternal zinc status is associated with adverse pregnancy outcomes as zinc is assumed to be essential for normal foetal growth and development ([@B4]). Animal experiments indicate that severe prenatal zinc deficiency is associated with spontaneous abortion and congenital malformations ([@B5]) whereas milder forms are attributed to low birthweight (LBW), intrauterine growth retardation (IUGR), and preterm delivery ([@B6]). Difficult and prolonged labour, haemorrhage, uterine dystocia, and placental abruption have also been documented in female rats fed zinc-deficient diets throughout pregnancy ([@B7]). The poor pregnancy outcomes in women with acrodermatitis enteropathica are also consistent with effects observed in zinc-deficient pregnant animals ([@B8]). However, studies that attempted to evaluate the effect of prenatal zinc status on maternal health and pregnancy outcomes in apparently healthy individuals yielded conflicting conclusions ([@B9]).

As to the effect of prenatal zinc supplementation on anthropometric indicators is concerned, of more than 20 RCTs conducted so far, few reported positive association between zinc supplementation and anthropometric measurements. According to a study in India, birthweight of infants born to women in the placebo group averaged only 2.6 kg ([@B10]). Infants born to zinc-supplemented mothers were 0.3-0.8 kg heavier, depending on the length of time supplemental zinc was provided for. If zinc supplementation was initiated in the first trimester, the effect on birthweight would be greater than if it was initiated in the third trimester ([@B10]). A study in the USA among disadvantaged African-American women reported that supplemented zinc increased birthweight by 126 g and increased head-circumference of infant by 0.4 cm ([@B11]). Another study in the USA ([@B12]) and a study in Chile ([@B13]) reported that zinc supplementation enhanced birthweight significantly---approximately by 150 and 69 g respectively. A study in Iran found significantly higher head-circumference of newborns in the supplemented group than in the control group (35.0 cm vs 33.7 cm) but no increments in birthweight ([@B14]). However, the remaining RCTs failed to witness any association between anthropometric indicators and prenatal zinc supplementation ([@B15]-[@B25]).

The objective of this systemic review and meta-analysis was to examine the effect of prenatal zinc supplementation on birthweight. A similar meta-analysis was published in 2009 by the Cochrane Collaboration Group ([@B26]). However, this analysis has included four more additional studies and provided the results based on both fixed and random effect models.

MATERIALS AND METHODS {#sec1_2}
=====================

Study design {#sec1_2_1}
------------

This is a systematic review which includes a meta-analysis.

Inclusion and exclusion criteria {#sec1_2_2}
--------------------------------

To assure the quality of analysis, only RCTs were included in the analysis. Articles written in only English language were considered. The exclusion criteria were set based on multiple criteria, including low dose of supplementation (less than 15 mg/day), unavailability of vital information in the articles (mean and standard deviation of birthweight in intervention and control arms, percentage of LBW babies in both arms) and low level of compliance (\<70%) for the supplement.

Search strategy and evaluation of studies {#sec1_2_3}
-----------------------------------------

Studies were mainly identified through web-based descendent (identifying key literature and look online the other studies which cite them) and ancestor (look into the references of a key article) search techniques. The study did not involve any manual search of articles or contacts with authors. The electronic search was performed within the Cochrane Library and MEDLINE databases. Further studies were identified using the Google Scholar search engine. Key combination search terms were "zinc supplementation and birthweight" and "zinc supplementation and birth outcomes". Literature written in only English language were considered, and no limit was made on date of publication of the articles.

Initially, 21 (20 published and 1 PhD dissertation) articles and abstracts based on RCTs were located. The principal investigators reviewed all of them using the predefined inclusion criteria. They also checked quality of the studies in terms of reasonable level of compliance for the supplementation (\>70% compliance), follow-up (\<30% loss to followup), and assuring the comparability of the intervention and control groups based on key variables (maternal age, educational status, maternal anthropometric indicators, gestational age, parity, etc.). Disagreements were solved by repeated evaluations and discussions.

Three of the 21 RCTs, conducted in Germany ([@B27]), USA ([@B28]) and Denmark ([@B29]), were excluded as vital information, such as mean and standard deviation of birthweight in intervention and control arms and proportion of LBW babies in both arms, could not be extracted from the articles and abstracts. A study in South Africa was also excluded since it used very low dose (4.3-12.9 mg/day) of zinc supplementation ([@B30]). Hence, the analysis was done with the remaining 17 studies.

From each of the studies included, information on total number of zinc-supplemented and control children, number of LBW babies (\<2,500 g), mean birthweight and standard deviation (SD) for both arms, nature of the population, and dose and duration of supplementation were extracted.

Analysis of data {#sec1_2_4}
----------------

The description of original studies was made using frequency and forest plot. Heterogeneity among studies was statistically assessed using Cochrane Q test statistic. The test statistic indicated random heterogeneity among studies (p=0.09). Hence, random effect model was used in the analysis. Among studies, variation was assessed using DerSimonian and Laird\'s (DL\'s) estimator. To control the effect of dose of supplementation (optimal or high dose), type of the study (community or institution-based), and type of source country (developed or developing), stratified analysis was made. We analyzed data using Metaeasy add-in for the MS Excel software (version 1.0). As relatively fewer articles were included in the analysis, Funnel plot was not used for assessing publication bias.

The strength of association between zinc supplementation and birthweight was assessed using effect-size which measures the strength or magnitude of difference between two sets of data (in this case treatment groups). It is the difference between the mean values of the two groups, divided by the standard deviation. The larger the effect-size, the greater is the difference or impact of an intervention. Cohen proposed operational definitions of 0.2, 0.5, and 0.8 as small, medium, and large effect-sizes respectively ([@B31]).

RESULTS {#sec1_3}
=======

Description of original studies {#sec1_3_1}
-------------------------------

Four studies from the USA, three from the UK, six from Asian countries, three from Latin American countries, and only one from Africa were included in the analysis. In total, these studies involved 6,209 pregnant women in intervention and control arms. The sample-size of the studies ranged from 1,075 in Nepal ([@B32]) to 52 in the UK ([@B18]). With the exception of six community-based studies, all were health institution-based. All the studies randomized the study subjects into intervention and control groups around the mid-point of the second trimester (16-20 weeks). The dose of the supplement in 12 studies was 15-25 mg/day. However, in the remaining five studies, a higher dose (25-62 mg/day) of supplementation was used. All the studies were published in the last 25 years (1984-2009). The basic information of each specific study is presented in [Table 1](#T1){ref-type="table"}.

###### 

Description of 17 randomized controlled trials on the association between prenatal zinc supplementation and birthweight, 1984-2009

  Author and year of publication          Country      Dose    Type   Intervention Group   Control group   Mean difference (g) (95% CI)   Total sample-size                         
  --------------------------------------- ------------ ------- ------ -------------------- --------------- ------------------------------ ------------------- --------------------- -------
  Goldenberg RL et al., 1995 ([@B11])     USA          25 mg   HIB    3,214 (669)          294             3,088 (728)                    286                 126 (12.1, 239.9)     580
  Hunt IF *et al*., 1985 ([@B15])         USA          20 mg   HIB    3,352 (430)          55              3,338 (592)                    51                  14 (-184.3, 212.3)    106
  Tamura T *et al*., 2003 ([@B12])        USA          25 mg   HIB    3,267 (592)          173             3,117 (666)                    182                 150 (19.1, 280.9)     355
  Hunt IF *et al*., 1984 ([@B16])         USA          20 mg   HIB    3,430 (509)          81              3,368 (442)                    64                  62 (-93.0, 217.0)     145
  Mahomed K *et al*., 1989 ([@B17])       UK           20 mg   HIB    3,291 (581)          247             3,319 (531)                    244                 -28 (-126.4, 70.4)    491
  Simmer K *et al*., 1991 ([@B18])        UK           23 mg   HIB    2,990 (540)          30              2,820 (600)                    22                  170 (-146.5, 486.5)   52
  Robertson JS *et al*., 1991 ([@B19])    UK           62 mg   HIB    3,264 (722)          72              3,220 (871)                    62                  44 (-229.5, 317.5)    134
  Caulfield LE *et al*., 1999 ([@B20])    Peru         15 mg   CB     3,267 (461)          488             3,300 (498)                    469                 -33 (-93.9,27.9)      957
  Merialdi M *et al*., 2004 ([@B21])      Peru         25 mg   CB     3,351 (427)          94              3,319 (389)                    101                 32 (-82.9,146.9)      195
  Hafez A *et al*., 2004 ([@B22])         Pakistan     20 mg   HIB    3,023 (456)          121             3,061 (444)                    121                 -38 (-151.4,75.4)     242
  Christian P *et al*., 2003 ([@B32])     Nepal        25 mg   CB     2,598 (428)          553             2,652 (429)                    522                 -54 (-105.3,−2.7)     1,075
  Danesh A *et al*., 2009 ([@B14])        Iran         30 mg   HIB    2,961(498)           42              2,819 (609)                    42                  142 (-95.9,379.9)     84
  Dijkhuizen MA *et al*., 2004 ([@B23])   Indonesia    25 mg   CB     3,200 (500)          84              3,150 (400)                    80                  50 (-88.3, 188.3)     164
  Saaka M *et al*., 2009 ([@B24])         Ghana        40 mg   HIB    3,105 (490)          272             3,120 (486)                    271                 -15 (-97.1, 67.1)     543
  Duran CC *et al*., 2001 ([@B13])        Chile        20 mg   CB     3,319 (460)          249             3,250 (514)                    258                 69 (-15.8, 153.8)     507
  Osendarp JM *et al*., 2009 ([@B25])     Bangladesh   30 mg   CB     2,513 (390)          194             2,554 (393)                    216                 -41 (-116.9, 34.9)    410
  Garg HK *et al*., 1993 ([@B10])         India        45 mg   CB     3,000 (513)          106             2,600 (541)                    62                  400 (233.6, 566.4)    168

CB=Community-based

CI=Confidence interval

HIB=Health institution-based

SD=Standard deviation

Pooled effect-size {#sec1_3_2}
------------------

The effect-size estimate of the specific studies showed that the majority (n=13) of the studies found no association between zinc supplementation and birthweight. Three studies reported positive association while one study reported negative association. Based on fixed and random effect model assumptions, the mean (pooled) effect-sizes were 0.0268 (95% CI 0.0764, −0.0229) and 0.0712 (95% CI 0.1619, −0.0194) respectively. In both the cases, the meta-analysis showed no significant association between birthweight and zinc supplementation. The specific and pooled effect-sizes are presented in the figure.

To control the possible effect of confounders, stratification was made based on type of country (developed or developing), dose of supplementation (optimal or high dose), and type of study (health institution-based or community-based). The classification into developed or developing country was made according to the World Bank cut-off point of gross national income per capita of US\$ 3,945 ([@B33]). The mean effect-sizes, based on the fixed and random effect models for the respective categories, are summarized in [Table 2](#T2){ref-type="table"}.

###### 

Mean effect-size in different categories of studies: 17 randomized controlled trials on the association between prenatal zinc supplementation and birthweight, 1984-2009

  Stratifying variable         Total sample-size of studies   Effect-size with 95% CI (fixed effect model)   Effect-size with 95% CI (random effect model)
  ---------------------------- ------------------------------ ---------------------------------------------- -----------------------------------------------
  Type of country                                                                                            
    Developed                  1,863                          0.107 (0.197, −0.017)                          0.107 (0.199, −0.016)
    Developing                 4,345                          -0.008 (0.051, −0.068)                         0.057 (0.183, −0.070)
  Type of study                                                                                              
    Community-based            3,476                          0.101 (0.174, 0.026)                           0.129 (0.267, −0.010)
    Health institution-based   2,732                          -0.031 (0.041, −0.103)                         0.075 (0.268, −0.118)
  Dose of supplementation                                                                                    
    15-25 mg/day               4,869                          0.016 (0.072, −0.040)                          0.040 (0.123, −0.043)
    26-62 mg/day               1,339                          0.067 (0.175, −0.041)                          0.169 (0.457, −0.119)

CI=Confidence interval

In all the categories, the Q test statistic was 0.5-0.05 and, as such, the random effect model was taken as the appropriate estimator of pooled effect-size. The stratification indicated that prenatal zinc supplementation was not associated with birthweight, irrespective of dose, type of study, and country.

DISCUSSION {#sec1_4}
==========

Another meta-analysis of 14 RCTs conducted by Cochrane group also failed to show any association between prenatal zinc supplementation and birthweight ([@B26]). According to this study, the pooled difference in the mean birthweight between the zinc supplemented and the control group was −10.59 g (95% CI −36.71, 15.54). Of 10 studies conducted in populations with low serum zinc or low dietary zinc intake, the pooled difference in the mean birthweight between the zinc-supplemented and the control group was −11.42 g (95% CI −38.82, to 15.98) ([@B26]). Of three studies conducted in population with normal zinc status or adequate dietary zinc intake, the pooled difference in the mean birthweight between the zinc-supplemented and the control group was-2.32 g (95% CI −88.94, to 84.30). In both the strata, zinc supplementation had no association with birthweight ([@B26]).

However, the finding of the two meta-analyses was not consistent to what is documented by many observational studies. In Japan, Higashi A *et al*. have demonstrated that maternal serum zinc level in the second trimester was not related to birthweight of infants ([@B34]); however, zinc status in the third trimester was an important determinant. A case-control study in Tanzania reported that mothers with low zinc levels were 2.6 times more at risk of having LBW babies compared to those with normal zinc levels, and newborns with low zinc levels were 2.8 times more at risk of being born with low weight ([@B35]). A study in the USA also found that, among both white and black mothers, serum zinc concentration was significantly related to birthweight after various independent determinants of birthweight were controlled ([@B36]). A similar association was also documented by studies in Turkey ([@B37]), India ([@B38]), and China ([@B39]).

The discrepancy between the conclusion of this analysis and the findings of many observational studies cannot be explained by non-compliance to zinc supplementation as all RCTs included in this analysis reported a satisfactory level of compliance. One possible reason might be the risk of potential confounding bias in observational studies. The other reason might be related to the bioavailability of zinc supplement. As absorption of dietary zinc can be inhibited by iron and phytate intake, the same might occur to zinc supplement. Hence, zinc level adequate to promote birthweight may not be achieved after the supplementation of zinc. This hypothesis is also supported by the findings of Hunt *et al.* in the USA ([@B40]). According to them, zinc supplementation among pregnant Hispanic women did not alter the mean zinc levels in serum or hair and did not increase the serum zinc level significantly compared to the pre-supplementation level ([@B40]).

![Forest plot of 17 randomized controlled trials on the association between prenatal zinc supplementation and birthweight, 1984-2009](jhpn0029-0134_uf01){#FU1}

As meta-analysis heavily depends upon published studies which are more likely to report significant results, non-significant studies which end up in the desk-drawer instead of the public domain would be systematically avoided. However, in this analysis, the problem of publication bias would be less significant as the focus of the analysis is a contemporary issue of scientific debate by which reporting any direction of association would be reasonably interesting to researchers and publishers.

Conclusions {#sec1_4_1}
-----------

The study did not witness any association between birthweight and zinc supplementation. However, the finding is not conclusive as possible confounding factors were not controlled. This does not mean that zinc status is not a possible predictor of birthweight as zinc supplementation status may not perfectly correlate with serum zinc level. The bioavailability of supplemental zinc should also be investigated.
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